157 related articles for article (PubMed ID: 35066757)
1. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
[TBL] [Abstract][Full Text] [Related]
2. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract][Full Text] [Related]
3. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
4. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression.
Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
[TBL] [Abstract][Full Text] [Related]
6. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
8. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1.
Zhai S; Xu Z; Xie J; Zhang J; Wang X; Peng C; Li H; Chen H; Shen B; Deng X
Oncogene; 2021 Jan; 40(2):277-291. PubMed ID: 33122827
[TBL] [Abstract][Full Text] [Related]
10. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
11. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
Wang X; Gao X; Tian J; Zhang R; Qiao Y; Hua X; Shi G
Arch Biochem Biophys; 2020 Aug; 689():108469. PubMed ID: 32590069
[TBL] [Abstract][Full Text] [Related]
12. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis.
Li JR; Liu L; Luo H; Chen ZG; Wang JH; Li NF
Pancreas; 2021 Mar; 50(3):317-326. PubMed ID: 33625109
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
15. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3.
Zou J; Pei X; Xing D; Wu X; Chen S
J Cell Mol Med; 2021 Oct; 25(20):9826-9836. PubMed ID: 34541823
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway.
Shi XY; Zhang XL; Shi QY; Qiu X; Wu XB; Zheng BL; Jiang HX; Qin SY
Clin Transl Oncol; 2022 Jun; 24(6):1073-1085. PubMed ID: 35037236
[TBL] [Abstract][Full Text] [Related]
20. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study.
Chen S; Zhang JQ; Chen JZ; Chen HX; Qiu FN; Yan ML; Chen YL; Peng CH; Tian YF; Wang YD
Int J Biol Macromol; 2017 Sep; 102():718-728. PubMed ID: 28344092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
